Boston Scientific (NYSE: BSX) director adds 2,100 shares in open-market buy
Rhea-AI Filing Summary
Boston Scientific director David C. Habiger purchased 2,100 shares of common stock on August 5, 2026 in an open-market transaction at a weighted average price of $47.589 per share, with individual trade prices between $47.21 and $47.98. Following this purchase, he directly owns 17,160 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,100 shares
Net Buy
1 txn
Insider
Habiger David C
Role
Director
Bought
2,100 shs ($100K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 2,100 | $47.589 | $100K |
Holdings After Transaction:
Common Stock — 17,160 shares (Direct)
Footnotes (1)
- F1. Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.21 to $47.98, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Key Figures
Shares purchased: 2,100 shares
Weighted average price: $47.589 per share
Purchase price range low: $47.21 per share
+3 more
6 metrics
Shares purchased
2,100 shares
Common Stock acquired on August 5, 2026
Weighted average price
$47.589 per share
Average purchase price for the 2,100 shares
Purchase price range low
$47.21 per share
Lowest price among multiple purchase transactions
Purchase price range high
$47.98 per share
Highest price among multiple purchase transactions
Shares owned after transaction
17,160 shares
Direct holdings of Common Stock following the purchase
Net shares bought
2,100 shares
Net buy reported in this Form 4
Key Terms
weighted average purchase price, open market or private transaction
2 terms
weighted average purchase price financial
"Represents the weighted average purchase price. These shares were purchased..."
The weighted average purchase price is the average cost per share you paid across multiple buys, calculated so larger purchases count more than smaller ones. Imagine buying apples at different prices: the overall price you effectively paid depends on how many apples you bought at each price. Investors use it to measure true cost basis, calculate gains or losses, decide when to sell, and manage taxes and portfolio performance.
open market or private transaction financial
"transaction code description: Purchase in open market or private transaction"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Boston Scientific (BSX) director David C. Habiger report?
David C. Habiger reported a purchase of 2,100 shares of Boston Scientific common stock on August 5, 2026. The transaction was reported as a director-level open-market trade in the company’s common stock.
What are David C. Habiger’s Boston Scientific (BSX) holdings after this purchase?
After the reported purchase, Habiger directly holds 17,160 shares of Boston Scientific common stock. This figure reflects his ownership immediately following the August 5, 2026 open-market acquisition of 2,100 additional shares.
Was Habiger’s Boston Scientific (BSX) trade an open-market purchase?
Yes. The Form 4 classifies the transaction with code P, described as a “Purchase in open market or private transaction”. The accompanying data show it as a direct ownership, non-derivative acquisition of common stock.